BofA Securities maintains Cano Health at 'underperform' with a price target of $0.25

An analyst from BofA Securities maintained Cano Health (NYSE: CANO ) at 'underperform' with a price target of $0.25 from a prior price target of $1.00.
Prior to this rating, Cano Health had 1 buy ratings, 6 hold ratings, and 2 sell ratings.
For consensus analyst estimates and price targets on Cano Health, click here. For more news on Cano Health, click here.
Cano Health's stock price closed at $0.36. They are down -79.07% in the last month and down -93.88% in the last 12 months.
According to Investing Pro, Cano Health's fair value is $0.46, an upside of 27.55%. Cano Health's fair value comes with a medium degree of uncertainty, according to InvestingPro.
Check out Cano Health's recent earnings performance and financials here.

Drop an image here or Supported formats: *.jpg, *.png, *.gif up to 5mb
Drop an image here or